Study type

Study topic

Human medicinal product

Study type

Clinical trial

If ‘other’, further details on the scope of the study

Educational Intervention
Clinical trials

Clinical trial regulatory scope

Clinical trial not part of marketing authorisation application or subject to marketing authorisation approval

Clinical trial randomisation

Randomised clinical trial

Clinical trial types

Cluster randomised trial
Single-arm trial
Population studied

Short description of the study population

All general practitioners working during the period of the study in the National System of Health (SNS).

Age groups

Preterm newborn infants (0 – 27 days)
Term newborn infants (0 – 27 days)
Infants and toddlers (28 days – 23 months)
Children (2 to < 12 years)
Adolescents (12 to < 18 years)
Adults (18 to < 46 years)
Adults (46 to < 65 years)
Adults (65 to < 75 years)
Adults (75 to < 85 years)
Adults (85 years and over)

Estimated number of subjects

0
Study design details

Main study objective

Improve antibiotic prescription.

Outcomes

Overall antibiotics prescription, 12 quality indicators of antibiotics consumption published by ESAC

Data analysis plan

It was used monthly prescription data for physician from National Health System-Centre Region of Portugal and aggregated by active substance in accordance with the Anatomical Therapeutic Chemical (ATC).